Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Genetics
Volume 2015, Article ID 926545, 7 pages
http://dx.doi.org/10.1155/2015/926545
Case Report

Unexplained False Negative Results in Noninvasive Prenatal Testing: Two Cases Involving Trisomies 13 and 18

1Department of Medical Genetics, Division of Biomedical Genetics, University Medical Centre Utrecht, P.O. Box 85090, Mail Stop KC04.084.2, 3508 AB Utrecht, Netherlands
2Department of Obstetrics and Gynecology, University Medical Centre Utrecht, P.O. Box 85090, Mail Stop KE04.123.1, 3508 AB Utrecht, Netherlands

Received 18 March 2015; Accepted 26 May 2015

Academic Editor: Philip D. Cotter

Copyright © 2015 R. Hochstenbach et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. W. K. Chiu, K. C. A. Chan, Y. Gao et al., “Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 51, pp. 20458–20463, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. H. C. Fan, Y. J. Blumenfeld, U. Chitkara, L. Hudgins, and S. R. Quake, “Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 42, pp. 16266–16271, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Benn, H. Cuckle, and E. Pergament, “Non-invasive prenatal testing for aneuploidy: current status and future prospects,” Ultrasound in Obstetrics and Gynecology, vol. 42, no. 1, pp. 15–33, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. E. R. Norwitz and B. Levy, “Noninvasive prenatal testing: the future is now,” Reviews in Obstetrics & Gynecology, vol. 6, no. 2, pp. 48–62, 2013. View at Google Scholar
  5. D. W. Bianchi and L. Wilkins-Haug, “Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road?” Clinical Chemistry, vol. 60, no. 1, pp. 78–87, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. G. J. W. Liao, A. M. Gronowski, and Z. Zhao, “Non-invasive prenatal testing using cell-free fetal DNA in maternal circulation,” Clinica Chimica Acta, vol. 428, pp. 44–50, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. K. H. Nicolaides, A. Syngelaki, G. Ashoor, C. Birdir, and G. Touzet, “Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population,” American Journal of Obstetrics & Gynecology, vol. 207, no. 5, pp. 374.e1–374.e6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Dan, W. Wang, J. Ren et al., “Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11 105 pregnancies with mixed risk factors,” Prenatal Diagnosis, vol. 32, no. 13, pp. 1225–1232, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. D. W. Bianchi, R. Lamar Parker, J. Wentworth et al., “DNA sequencing versus standard prenatal aneuploidy screening,” The New England Journal of Medicine, vol. 370, no. 9, pp. 799–808, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. E. Norton, B. Jacobsson, G. K. Swamy et al., “Cell-free DNA analysis for noninvasive examination of trisomy,” The New England Journal of Medicine, vol. 372, no. 17, pp. 1589–1597, 2015. View at Publisher · View at Google Scholar
  11. P. Benn, A. Borell, R. Chiu et al., “Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis,” Prenatal Diagnosis, vol. 33, no. 7, pp. 622–629, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. A. R. Gregg, S. J. Gross, R. G. Best et al., “ACMG statement on noninvasive prenatal screening for fetal aneuploidy,” Genetics in Medicine, vol. 15, no. 5, pp. 395–398, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. D. H. Ledbetter, J. M. Zachary, J. L. Simpson et al., “Cytogenetic results from the U.S. collaborative study on CVS,” Prenatal Diagnosis, vol. 12, no. 5, pp. 317–345, 1992. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Hahnemann and L. O. Vejerslev, “Accuracy of cytogenetic findings on chorionic villus sampling (CVS)—diagnostic consequences of CVS mosaicism and non-mosaic discrepancy in centres contributing to eucromic 1986–1992,” Prenatal Diagnosis, vol. 17, no. 9, pp. 801–820, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Brady, N. Brison, K. Van Den Bogaert et al., “Clinical implementation of NIPT—technical and biological challenges,” Clinical Genetics, 2015. View at Publisher · View at Google Scholar
  16. G. Ashoor, A. Syngelaki, L. C. Y. Poon, J. C. Rezende, and K. H. Nicolaides, “Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics,” Ultrasound in Obstetrics and Gynecology, vol. 41, no. 1, pp. 26–32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Canick, G. E. Palomaki, E. M. Kloza, G. M. Lambert-Messerlian, and J. E. Haddow, “The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies,” Prenatal Diagnosis, vol. 33, no. 7, pp. 667–674, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Wang, A. Batey, C. Struble, T. Musci, K. Song, and A. Oliphant, “Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma,” Prenatal Diagnosis, vol. 33, no. 7, pp. 662–666, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. R. Fernando, K. Chen, S. Norton et al., “A new methodology to preserve the original proportion and integrity of cell-free fetal DNA in maternal plasma during sample processing and storage,” Prenatal Diagnosis, vol. 30, no. 5, pp. 418–424, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. N. Barrett, B. G. Zimmermann, D. Wang, A. Holloway, and L. S. Chitty, “Implementing prenatal diagnosis based on cell-free fetal DNA: accurate identification of factors affecting fetal DNA yield,” PLoS ONE, vol. 6, no. 10, Article ID e25202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. R. P. Rava, A. Srinivasan, A. J. Sehnert, and D. W. Bianchi, “Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X,” Clinical Chemistry, vol. 60, no. 1, pp. 243–250, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Pergament, H. Cuckle, B. Zimmermann et al., “Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort,” Obstetrics & Gynecology, vol. 124, no. 2, part, pp. 210–218, 2014. View at Publisher · View at Google Scholar
  23. A. Gerovassili, C. Garner, K. H. Nicolaides, S. L. Thein, and D. C. Rees, “Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities?” Prenatal Diagnosis, vol. 27, no. 2, pp. 104–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. P. Porreco, T. J. Garite, K. Maurel et al., “Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA,” American Journal of Obstetrics and Gynecology, vol. 211, pp. 365.e1–365.e12, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Gao, D. Stejskal, F. Jiang, and W. Wang, “False-negative trisomy 18 non-invasive prenatal test result due to 48,XXX,+18 placental mosaicism,” Ultrasound in Obstetrics and Gynecology, vol. 43, no. 4, pp. 477–478, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Mao, T. Wang, B.-J. Wang et al., “Confined placental origin of the circulating cell free fetal DNA revealed by a discordant non-invasive prenatal test result in a trisomy 18 pregnancy,” Clinica Chimica Acta, vol. 433, pp. 190–193, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. Pan, B. Sun, X. Huang et al., “A prenatal case with discrepant findings between non-invasive prenatal testing and fetal genetic testings,” Molecular Cytogenetics, vol. 7, article 48, 2014. View at Publisher · View at Google Scholar
  28. H. Zhang, Y. Gao, F. Jiang et al., “Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146, 958 pregnancies,” Ultrasound in Obstetrics & Gynecology, vol. 45, no. 5, pp. 530–538, 2015. View at Publisher · View at Google Scholar
  29. Y. Wang, J. Zhu, Y. Chen et al., “Two cases of placental T21 mosaicism: challenging the detection limits of non-invasive prenatal testing,” Prenatal Diagnosis, vol. 33, no. 12, pp. 1207–1210, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Smith, K. M. Lewis, A. Holmes, and J. Visootsak, “A case of false negative NIPT for Down syndrome-lessons learned,” Case Reports in Genetics, vol. 2014, Article ID 823504, 3 pages, 2014. View at Publisher · View at Google Scholar
  31. J.-C. Wang, T. Sahoo, S. Schonberg et al., “Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases,” Genetics in Medicine, vol. 17, no. 3, pp. 234–236, 2015. View at Publisher · View at Google Scholar
  32. P. Dar, K. J. Curnow, S. J. Gross et al., “Clinical experience and follow-up with large scale single-nucleotide polymorphism–based noninvasive prenatal aneuploidy testing,” American Journal of Obstetrics & Gynecology, vol. 211, no. 5, pp. 527.e1–527.e17, 2014. View at Publisher · View at Google Scholar
  33. C. J. Beamon, E. E. Hardisty, S. C. Harris, and N. L. Vora, “A single center's experience with noninvasive prenatal testing,” Genetics in Medicine, vol. 16, no. 9, pp. 681–687, 2014. View at Publisher · View at Google Scholar
  34. M. S. Quezada, M. M. Gil, C. Francisco, G. Oròsz, and K. H. Nicolaides, “Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11–13 weeks,” Ultrasound in Obstetrics & Gynecology, vol. 45, no. 1, pp. 36–41, 2015. View at Publisher · View at Google Scholar
  35. P. J. Willems, H. Dierickx, E. Vandenakker et al., “The first 3,000 non-invasive prenatal tests (NIPT) with the harmony test in Belgium and the Netherlands,” Facts, Views & Vision in ObGyn, vol. 6, no. 1, pp. 7–12, 2014. View at Google Scholar
  36. R. Hochstenbach, P. G. Nikkels, M. G. Elferink et al., “Cell-free fetal DNA in the maternal circulation originates from the cytotrophoblast: proof from an unique case,” Clinical Case Reports, 2015. View at Publisher · View at Google Scholar
  37. G. H. Shuring-Blom, M. Keijzer, M. E. Jakobs et al., “Molecular cytogenetic analysis of term placentae suspected of mosaicism using fluorescence in situ hybridization,” Prenatal Diagnosis, vol. 13, no. 8, pp. 671–679, 1993. View at Publisher · View at Google Scholar · View at Scopus
  38. G. H. Schuring-Blom, K. Boer, and N. J. Leschot, “A placental diploid cell line is not essential for ongoing trisomy 13 or 18 pregnancies,” European Journal of Human Genetics, vol. 9, no. 4, pp. 286–290, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. F. R. Grati, F. Malvestiti, J. C. Ferreira et al., “Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results,” Genetics in Medicine, vol. 16, no. 8, pp. 620–624, 2014. View at Publisher · View at Google Scholar
  40. International Organization for Standardization, “Medical laboratories—requirements for quality and competence,” ISO 15189:2012, International Organization for Standardization, Geneva, Switzerland, 2012. View at Google Scholar
  41. M. T. Mennuti, A. M. Cherry, J. J. D. Morrissette, and L. Dugoff, “Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?” American Journal of Obstetrics and Gynecology, vol. 209, no. 5, pp. 415–419, 2013. View at Publisher · View at Google Scholar · View at Scopus